Scientists at Berkley say that, “The CRISPR-Cas9 technology, which is only four years old, is improving by leaps and bounds and has already altered the way doctors approach disease and scientists do research. The tests have shown that the technology can cure the defect that causes sickle cell anemia, and we are moving toward clinical trials within a few years (Wang).” But there are also people who speculate of this new way of toying with nature. In 1954 the book “I Am Legend” was written in it scientist have found a bacterium that can alter genes, just like CRISPR-cas9. “With so many unanswered questions, it is important to keep expectations of CRISPR under control”, says Katrine Bosley, chief executive of Editas, a company in Cambridge, Massachusetts, that is pursuing CRISPR-mediated gene therapy
Scientists at Berkley say that, “The CRISPR-Cas9 technology, which is only four years old, is improving by leaps and bounds and has already altered the way doctors approach disease and scientists do research. The tests have shown that the technology can cure the defect that causes sickle cell anemia, and we are moving toward clinical trials within a few years (Wang).” But there are also people who speculate of this new way of toying with nature. In 1954 the book “I Am Legend” was written in it scientist have found a bacterium that can alter genes, just like CRISPR-cas9. “With so many unanswered questions, it is important to keep expectations of CRISPR under control”, says Katrine Bosley, chief executive of Editas, a company in Cambridge, Massachusetts, that is pursuing CRISPR-mediated gene therapy